AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) today announced the pricing of its previously announced underwritten public offering of 7,272,727 shares ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE